1428581-35-4

Basic information

• Product Name: N-((1-(4-(3-cyanophenyl)-1,3,5-triazin-2-yl)piperidin-4-yl)methyl)-3-ethoxy-5-methoxybenzamide
• Synonyms: N-((1-(4-(3-cyanophenyl)-1,3,5-triazin-2-yl)piperidin-4-yl)methyl)-3-ethoxy-5-methoxybenzamide
• CAS NO: 1428581-35-4
• Molecular Weight: 472.547
• Mol File: 1428581-35-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-((1-(4-(3-cyanophenyl)-1,3,5-triazin-2-yl)piperidin-4-yl)methyl)-3-ethoxy-5-methoxybenzamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-((1-(4-(3-cyanophenyl)-1,3,5-triazin-2-yl)piperidin-4-yl)methyl)-3-ethoxy-5-methoxybenzamide(1428581-35-4)
• EPA Substance Registry System: N-((1-(4-(3-cyanophenyl)-1,3,5-triazin-2-yl)piperidin-4-yl)methyl)-3-ethoxy-5-methoxybenzamide(1428581-35-4)

Safety Data

• Hazardous Substances Data: 1428581-35-4(Hazardous Substances Data)

Upstream product

• 1428582-11-9 N-((1-(4-(3-cyanophenyl)-1,3,5-triazin-2-yl)piperidin-4-yl)methyl)-3-hydroxy-5-methoxybenzamide 
• 75-03-6 ethyl iodide 
• 19520-75-3 3-hydroxy-5-methoxybenzoic acid 

Relevant articles and documents

N-PIPERIDIN-4-YL DERIVATIVES

The invention relates to a N-piperidin-4-yl derivative having the general Formula I or a pharmaceutically acceptable salt thereof, to pharmaceutical compositions comprising the same and to the use of said N-piperidin-4-yl derivatives for the treatment and prevention of endometriosis, for the treatment and prevention of pre-menopausal and peri-menopausal hormone-dependent breast cancer, for contraception, or for the treatment of uterine fibroids or other menstrual-related disorders.